John Maraganore
Chief Executive Officer at Alnylam Pharmaceuticals; Director at City Therapeutics; Director at Hemab Therapeutics Holdings. Based in Boston, Massachusetts.
- Rank
- 1987th of 14,644
- Companies held
- 6
- Largest holding
- ALNY, 48.9% of total
- Latest SEC filing
- Oct 22, 2026
- Listed but not counted
- $223K
What the $70.5M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Alnylam Pharmaceuticals ALNY Common Stock | Directly | 227,663 | $149.37 | $34.0M | 48.2% | Form 4, Dec 22, 2021 |
| City Therapeutics CTY Common Stock | Directly | 1,470,692 | $18.39 | $27.0M | 38.4% | Form 4, Oct 19, 2026 |
| City Therapeutics CTY Common Stock | Through John M. Maraganore 2021 Irrevocable Trust | 318,507 | $18.39 | $5.9M | 8.3% | Form 4, Oct 15, 2026 |
| Hemab Therapeutics Holdings COAG Common Stock | Directly | 35,948 | $39.35 | $1.4M | 2.0% | Form 4, May 4, 2026 |
| Agios Pharmaceuticals AGIO Common stock | Directly | 28,528 | $29.12 | $831K | 1.2% | Form 5, Sep 20, 2022 |
| ProKidney PROK Class B Ordinary Shares | Directly | 614,013 | $1.08 | $660K | 0.9% | Form 4, Jul 11, 2022 |
| Alnylam Pharmaceuticals ALNY Common Stock | Through Managed Account | 3,133 | $149.37 | $468K | 0.7% | Form 4, Dec 21, 2021 |
| Rapport Therapeutics RAPP Common Stock | Through John M. Maraganore Revocable Trust | 9,411 | $23.56 | $222K | 0.3% | Form 4, Oct 22, 2026 |
Share counts are the amounts John Maraganore reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Reported but not counted
These shares appear on John Maraganore's filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.
| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Takeda Pharmaceutical Company TAK Ordinary Shares | Directly Not valued: reported in home-market shares, which trade in the US as depositary shares at a different ratio | 10,400 | $21.45 | $223K | — | Form 4, Jul 1, 2026 |
Open-market trades, last 12 months
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 1984 | Michael E. Maroone Director, Carvana. Tempe, AZ | $70.6M |
| 1985 | Steven Henry Gunby CEO, Chairman and President, FTI Consulting. Washington, DC | $70.5M |
| 1986 | Satish Chitoori Chief Operations Officer, Bloom Energy. San Jose, CA | $70.5M |
| 1987 | John Maraganore Chief Executive Officer, Alnylam Pharmaceuticals. Boston, MA | $70.5M |
| 1988 | Bancorp Mhc Winchester 10% owner, Winchester Bancorp. Winchester, MA | $70.4M |
| 1989 | Krishna Kantheti 10% owner, Ouster. Miami, FL | $70.2M |
| 1990 | Andreas Wicki Director, Harmony Biosciences Holdings | $70.2M |
Other Alnylam Pharmaceuticals insiders
All ALNY insiders- Phillip A. Sharp$39.9MDirector. #2937 overall
- Yvonne Greenstreet$12.7MChief Executive Officer. #7155 overall
- Jeffrey Poulton V.$9.2MEVP, Chief Financial Officer. #9351 overall
- Tolga Tanguler$5.1MEVP, Chief Commercial Officer. #14270 overall
- David E. I. Pyott$5.0MDirector. #9619 overall
- Akshay Vaishnaw$3.5MPresident. #3327 overall
Questions
How much stock does John Maraganore own?
John Maraganore holds $70,495,498 in listed stock based on SEC filings and current prices, mostly Alnylam Pharmaceuticals (ALNY). That ranks 1987th on the Stock Rich List.
Is this John Maraganore's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did John Maraganore last buy or sell stock?
The most recent open-market trade on file is a purchase of 8,239 RAPP shares on Oct 22, 2026 at $26.38.